Chief Executive Officer and Director at Alzamend Neuro, Inc. - Salt Lake City, UT, US
Chairman Audit Committee
Contact Mark Gustafson
Check out this offering: NOW ACCEPTING INVESTORS IN ITS $50 MILLION BIOTECH MINI-IPO